Form 8-A12B - Registration of securities [Section 12(b)]:
SEC Accession No. 0001193125-21-297781
Filing Date
2021-10-13
Accepted
2021-10-13 16:01:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 8-A12B d232393d8a12b.htm 8-A12B 13183
  Complete submission text file 0001193125-21-297781.txt   14259
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: 8-A12B | Act: 34 | File No.: 001-40908 | Film No.: 211321257
SIC: 2836 Biological Products, (No Diagnostic Substances)